AstraZeneca Pharma rallies on strong response for OFS

The promoter had received bids for 18.25 million shares against 3.7 million shares offered for sale.

Image
SI Reporter Mumbai
Last Updated : May 29 2013 | 12:37 PM IST
AstraZeneca Pharma India has rallied 17% to Rs 783 after the promoter received a strong response for share sale offer.

AstraZeneca Pharmaceuticals AB Sweden, the promoter’s of the company proposed to sell around 3.7 million equity shares via offer-for-sale (OFS) was oversubscribed by almost five times.

The promoter had received bids for 18.25 million shares at indicative price of Rs 567.22 per share against floor price of Rs 490 per share, provisional data from BSE showed.

AstraZeneca Pharma said that the bids at or above the clearing price of Rs 620 have been considered for allocation.

The promoter who own 90% of the company has proposed to sell its stake to meet the Sebi's requirement of having at least 25% public shareholding mandatory for private listed companies by end-June.

The stock opened at Rs 697 and hit a high of Rs 801, recovering its entire previous day’s losses, on BSE. On Tuesday, the stock closed 16% lower after fixing the floor price at huge discount. The stock has rallied 23% from low of Rs 650 touched on Monday.

The counter has seen huge trading activity with a combined 2.17 million shares changing hands till noon deals against an average less than 0.50 million shares that were traded daily in past two weeks on BSE and NSE.
 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 29 2013 | 12:34 PM IST

Next Story